Tissue plasminogen activator (tPA) usage was not associated with pneumonia; among 52 stroke patients in training set who received tPA, only three had pneumonia among 33 stroke patients in test set who received tPA, only one had pneumonia. The gene discussed is PLAT; the disease is susceptibility to pneumonia measurement.